U.S. medical device manufacturer Medtronic says it has agreed to buy Ireland-based competitor Covidien for $42.9 billion in cash and stock, a 29 percent premium on Covidien's stock price.
from Business News Headlines - Yahoo! News http://ift.tt/1q2aivU
via IFTTT
from Business News Headlines - Yahoo! News http://ift.tt/1q2aivU
via IFTTT
No comments:
Post a Comment